Buprenorphine vs. oxycodone for pain after lung surgery
Treatments studied
Part of Pain clinical trials.
This study compares two common pain medicines given through a patient-controlled pump after lung surgery done with small incisions. The goal is to see which one works better and has fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for elective (planned) lung surgery using a small camera (VATS technique).
- Your health status is classified as ASA I, II, or III (generally healthy to mild to moderate illness).
- You will likely use a patient-controlled analgesia (PCA) pump to manage your pain after surgery.
- You are not regularly taking opioid pain medicine or other strong pain medications for a chronic condition.
- You do not have severe kidney or liver problems, and you are not pregnant or breastfeeding.
- You are not allergic to any of the study medicines (buprenorphine or oxycodone).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial aims to determine the most effective dose of oxycodone to treat acute pain after a first-time, one-sided, thoracoscopic lobectomy (a type of lung surgery). It may help identify the best amount of medicine to give patients right after surgery.
This study tests a skin patch that releases buprenorphine, a pain medicine, to control pain after lung surgery. It may help reduce pain and the need for other pain medicines.
This study compares two ways to manage pain after lung cancer surgery: one uses only non-opioid medicines, the other uses traditional opioids. The goal is to see if avoiding opioids can provide better pain relief with fewer side effects.
This study compares two types of numbing medicine (liposomal vs. hydrochloride bupivacaine) injected near the ribs during lung surgery. The goal is to see which one provides better pain relief after the operation.
This trial tests if a long-acting numbing medicine called liposomal bupivacaine can reduce pain after video-assisted lung surgery. It aims to help patients feel better after the procedure with less need for other painkillers.
This study tests whether a long-lasting numbing medicine (liposomal bupivacaine) injected near the spine can better control pain after lung surgery. It compares this to a standard numbing medicine, and aims to help patients recover with less pain after surgery.
Hear when a new Chronic Postoperative Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.